Tag
#LFMD
-
2026
-
LifeMD Offers Novo Nordisk’s Industry-First Wegovy® Telehealth Subscription Program
-
Novo Nordisk launches first and only multi-month subscription program for FDA-approved Wegovy®, offering savings of up to $1,200/year
-
LifeMD Declares Quarterly Dividend on Series A Cumulative Perpetual Preferred Stock
-
LifeMD Declares Quarterly Dividend on Series A Cumulative Perpetual Preferred Stock
-
LFMD – 8-K
-
LifeMD Appoints Veteran Healthcare Finance Executive as Chief Financial Officer and Expands Leadership Team
-
LFMD – 10-K
-
LifeMD Reports Fourth Quarter and Full Year 2025 Results
-
LFMD – 8-K
-
LifeMD Reports Fourth Quarter and Full Year 2025 Results
-
LifeMD to Participate in Two Investor Conferences During March
-
LifeMD to Participate in Two Investor Conferences During March
-
LifeMD to Report Fourth Quarter 2025 Financial Results on March 9
-
LifeMD to Report Fourth Quarter 2025 Financial Results on March 9